February 25, 2026 a 11:43 am
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc., operating primarily in the healthcare sector, demonstrates a stable yet slightly conservative growth pattern. With strengths in its proprietary and contract-manufactured products segments, WST has the potential for steady financial performance. However, market fluctuations and regulatory challenges are factors to be cautiously monitored.
Fundamental Rating
Analyzing the fundamental ratios, West Pharmaceutical shows an average performance across most financial metrics.
| Category | Score (1-5) | Visual |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The comparison with historical scores highlights a consistency in their financial metrics over time.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-24 | 3 | 3 | 4 | 5 | 3 | 1 | 1 |
| Previous | 0 | 3 | 4 | 5 | 3 | 1 | 1 |
Analyst Price Targets
Analyst estimates reflect a positive outlook with a majority leaning towards a bullish trend.
| High | Low | Median | Consensus |
|---|---|---|---|
| $340 | $265 | $311 | $304.43 |
Analyst Sentiment
The majority of analysts recommend a 'Buy', indicating confidence in the stock's future performance.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. stands out in its industry due to solid performance across various financial metrics. While the stock may face volatility due to external factors, its commitment to innovation and solid market position provides a safe harbor for long-term investors. The current analyst sentiment indicates a favorable outlook, though close monitoring of market trends is advised. With a balance of growth potential and inherent risks, WST appears to be a prudent choice for a diversified portfolio. However, investors should remain vigilant of regulatory changes and industry disruptions.